Cite
HARVARD Citation
Notsumata, K. et al. (2020). Early changes in tubular dysfunction markers and phosphorus metabolism regulators as a result of switching from entecavir to tenofovir alafenamide fumarate nucleoside analog therapy for chronic hepatitis B patients. Hepatology research. 50 (3), pp. 402-404. [Online].